NCT04351711View on ClinicalTrials.gov

Immunological Profiling of Patients With COVID-19 in Respiratory Distress

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

April 9, 2020

Primary Completion Date

June 9, 2023

Study Completion Date

April 11, 2024

Conditions
SARS-CoV-2Covid-19
Interventions
OTHER

Immunological profiling

The immune activation phenotype will be assessed using a standardized panel of soluble and membrane immune activation markers

OTHER

Immunological profiling

The immune activation phenotype will be assessed using a standardized panel of soluble and membrane immune activation markers

Trial Locations (1)

Unknown

CHU de Nimes, Nîmes

All Listed Sponsors
collaborator

Institute of Human Genetics, Montpellier

UNKNOWN

lead

Centre Hospitalier Universitaire de Nīmes

OTHER

NCT04351711 - Immunological Profiling of Patients With COVID-19 in Respiratory Distress | Biotech Hunter | Biotech Hunter